由于大流行，阿得拉和其他多动症药物的短缺加剧。 Adderall and other ADHD medication shortage escalates due to pandemic.
随着阿得拉和其他多动症药物的持续短缺，人们的挫败感不断增加，导致数百万人难以获得处方兴奋剂药物。 Frustrations rise as the shortage of Adderall and other ADHD medications continues, leaving millions of people struggling to obtain prescription stimulant medication. 多种因素共同加剧了这种情况，包括 COVID-19 大流行、制造问题以及兴奋剂处方的增加。 The situation has been exacerbated by a combination of factors, including the COVID-19 pandemic, manufacturing issues, and increased prescriptions for stimulants. 这种短缺导致了全国范围内的临床心理健康危机，人们在配药方面遇到困难，药店也正在适应阿得拉（Adderall）、Vyvanse 和 Concerta 等药物的持续短缺。 The shortage has led to a nationwide crisis in clinical mental health, with people experiencing difficulty in filling prescriptions and pharmacies adjusting to the ongoing shortages of drugs like Adderall, Vyvanse, and Concerta.